US › Healthcare

Ironwood Pharmaceuticals Inc (IRWD)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$4.31-2.49%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$106.5M
Revenue YoY
+158.9%
Net profit
$40.8M
Profit YoY
+209.1%
EPS
$0.24
EPS estimate
$0.24
Net margin
38.3%

EPS came in at 0.24 against a street estimate of 0.24 — a beat of 0.0%.

Key statistics

Market cap
$696.3M
P/E
6.8
Forward P/E
12.3
P/B
2.59
Book value
$-1.32
EPS (TTM)
$0.62
52-week high
$5.78
52-week low
$0.71
50-day MA
$3.85
200-day MA
$3.65
Beta
0.21

Analyst view

Analysts rate Ironwood Pharmaceuticals Inc a hold (0 buy, 4 hold, 0 sell out of 4) with an average price target of $6.35.

Shareholding

Insiders
3.16%
Institutions
98.87%

Largest institutional holders

FundStake
Vanguard Group Inc9.69%
Armistice Capital, LLC9.13%
BlackRock Inc8.12%
Sarissa Capital Management LP5.58%
Bank of America Corp5.27%
Renaissance Technologies Corp4.90%
AQR Capital Management LLC4.58%
State Street Corp4.53%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Ironwood Pharmaceuticals Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.